ML20023A643

GL Report from Teva Pharmaceuticals Regarding Transfer of Tritium Exit Signs on 11/01/2019

ML20023A643
Person / Time
Issue date:	11/01/2019
From:	Reichart D Teva Pharmaceuticals
To:	Office of Nuclear Material Safety and Safeguards
References
Download: ML20023A643 (5)